Merchants Bancorp
MBIN · NASDAQ
About MBIN
- Employees
- 735
- Headquarters
- Carmel, Indiana
- Listed
- Oct 26, 2017
- Sector
- Financials
- Industry
- Financial Services
- Website
- merchantsbankofindiana.com
MBIN key statistics
- Market cap
- 2.19B
- Price-earnings ratio
- 9.56
- Dividend yield
- 2.76%
- Average volume
- 161.03K
- Volume
- 173.22K
- Open price
- $47.81
- High today
- $49.15
- Low today
- $47.81
- 52 Week high
- $56.87
- 52 Week low
- $30.37
Merchants Bancorp (MBIN) at a glance
As of Oct 20, 2026, Merchants Bancorp (MBIN) shares are priced at $48.42, giving the company a market cap of 2.19B, a price-to-earnings ratio of 9.56 and a dividend yield of 2.76%.
Today the stock has traded between $47.81 and $49.15. The current price is 1.3% above the day's low and 1.5% below its high.
Volume so far is 173.22K shares, in line with the average of 161.03K shares a day.
Over the past year Merchants Bancorp has ranged from $30.37 to $56.87, and now sits 68% of the way up that range.
Merchants Bancorp met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $1.48 per share against an estimate of $1.24.
The average analyst price target is $65.79, 35.9% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy33.3%
- Hold66.7%
- Sell0.0%
- Low
- $64.64
- Now
- $48.42
- High
- $68.25
MBIN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 24.0% on average.
- Q3 FY24: reported $1.17 per share against an estimate of $1.45
- Q4 FY24: reported $1.85 per share against an estimate of $1.32
- Q1 FY25: reported $1.04 per share against an estimate of $1.28
- Q2 FY25: reported $0.60 per share against an estimate of $1.14
- Q3 FY25: reported $0.97 per share against an estimate of $0.8051
- Q4 FY25: reported $1.28 per share against an estimate of $0.9574
- Q1 FY26: reported $1.25 per share against an estimate of $1.17
- Q2 FY26: reported $1.48 per share against an estimate of $1.24
MBIN news
- Press releasePRNewswire
- Press releasePRNewswire
Merchants Bancorp Reports Second Quarter of 2026 Results
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merchants Bancorp - MBIN
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merchants Bancorp - MBIN
- Press releasePRNewswire
Merchants Bancorp Declares Quarterly Common and Preferred Dividends
- Press releasePRNewswire
Merchants Bancorp (MBIN) Securities Fraud Investigation - Levi & Korsinsky
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merchants Bancorp - MBIN
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merchants Bancorp - MBIN
Similar companies
Companies in the same industry as Merchants Bancorp
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.